Maternal Vitamin Use, Genetic Variation of Infant Methylenetetrahydrofolate Reducatase, and Risk for spina Bifida

Shaw, Gary M.; Rozen, Rima; Finnell, Richard H.; Wasserman, Cathy R.; Lammer, Edward J.
July 1998
American Journal of Epidemiology;Jul1998, Vol. 148 Issue 1, p30
Academic Journal
Maternal periconceptional use of vitamin supplements containing folic acid substantially reduces the risk of neural tube defects (NTDs) in the offspring. The mechanism underlying this reduction in risk is unknown. Several recent studies have reported an association between homozygosity for a variant form (the C677T genotype) of the 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene and risk for NTDs in individuals. It has been hypothesized that maternal folic acid supplementation prevents NTDs by partially correcting reduced MTHFR activity associated with the variant form of the enzyme. Using data from two California case-control interview studies (1987–1991 birth cohorts), the authors investigated whether an interaction for spina bifida risk existed between infant MTHFR C677T genotype and maternal use of supplements containing folic acid. The authors genotyped the allelic variants of MTHFR in 214 liveborn case infants with spina bifida and 503 control infants for whom information on maternal periconceptional vitamin use was available. The percentage of all case infants with the C677T MTHFR mutation, for both homozygous (TT) and heterozygous (TC) genotypes, was slightly higher than that of controls. The C677T genotype was substantially more frequent among both case and control Hispanic infants than among non-Hispanic infants. Among all infants whose mothers did not periconceptionally use vitamins containing folic acid, the risk of spina bifida, as measured by the odds ratio, was 1.6 (95% confidence interval (Cl) 0.8–3.1) for all infants with the TT genotype and 2.0 (95% Cl 0.5–7.4) for non-Hispanic white infants with the TT genotype, as compared with infants with the CC genotype. This result indicates a modestly increased risk associated with the C677T genotype. A lower risk estimate (odds ratio = 1.2, 95% Cl 0.4–4.0) was observed among infants whose mothers periconceptionally used vitamin supplements containing folic acid. This population-based California study found a modestly increased risk of spina bifida among infants who were homozygous for the C677T genotype, but only minimal evidence of an interaction between the C677T genotype and maternal folic acid intake in the occurrence of spina bifida. If this mutant MTHFR genotype plays a role in the association between maternal vitamin use and NTD risk, it may be a small role, or it may be conditional on maternal genotype. Am J Epidemiol 1998; 148: 30–7.


Related Articles

  • Meningomiyelosel ve Arnold-Chiari malformasyonu: 45 vakanın deÄŸerlendirilmesi. Çelik, H. Tolga; Meliboyev, Mavlon; Nizamov, İhtiyar; Yurdakök, Murat // Cocuk Sagligi ve Hastaliklari Dergisi;oca-mar2010, Vol. 53 Issue 1, p10 

    The aim of this study was to evaluate retrospectively the patients born in our hospital with neural tube defects. We investigated the demographic, prenatal, natal and postnatal features, familial risk factors, physical and radiological findings, and accompanying diseases of 45 (19 females, 26...

  • KNOWLEDGE AND USAGE PATTERN OF FOLIC ACID AMONG MEDICAL STUDENTS OF RAWALPINDI. Chaudhri, Shahana; Kamran, Javeria; Atif, Rabia; Gilani, Rehma; Ihsan, Siddra; Shahid, Afshan; Inam, Hafsa // Pakistan Armed Forces Medical Journal;2019 Supplement2, Vol. 69, pS297 

    Background: Neural Tube Defects (NTDs) are birth defects of brain and spinal cord that can result in permanent damage to the brain, resulting in lifelong disability or even death. The NTDs include spina bifida, anencephaly, hydrocephalus etc. NTDs affect 0.5-12 in every 1000 pregnancies...

  • Folate and neural tube defects.  // American Journal of Clinical Nutrition;Jan2007 Supplement, Vol. 85, p285S 

    The article focuses on the protective effect of folate in the development of neural tube defects (NTDs), such as anencephaly and spina bifida. Topics discussed include mandate of folic acid fortification in U.S. and other countries, congenital malformation has caused increase in fetal and infant...

  • Intrauterine Myelomeningocele Repair Reverses Preexisting Hindbrain Herniation. Tulipan, Noel; Hernanz-Schulman, Marta; Lowe, Lisa H.; Bruner, Joseph P. // Pediatric Neurosurgery;Sep99, Vol. 31 Issue 3, p137 

    Background: It has been reported that intrauterine myelomeningocele repair reduces the amount of hindbrain herniation normally seen in association with the Chiari type II malformation. It is not yet known, however, whether hindbrain herniation is prevented, or whether preexisting herniation is...

  • Bayesian Small Area Cluster Analysis of Neural Tube Defects in Newfoundland. Sloka, J. Scott; Crowley, Marian; Fernandez, Bridget; Maroun, Falah // Canadian Journal of Public Health;Sep/Oct2006, Vol. 97 Issue 5, p393 

    Background: The incidence of neural tube defects (NTDs) is declining worldwide due to the implementation of folic acid supplementation programs. Such a program was implemented over 1996–97 in Newfoundland and Labrador, Canada. The geographical distribution of birth incidence was studied...

  • A Genetic Signature of Spina Bifida Risk from Pathway-Informed Comprehensive Gene-Variant Analysis. Marini, Nicholas J.; Hoffmann, Thomas J.; Lammer, Edward J.; Hardin, Jill; Lazaruk, Katherine; Stein, Jason B.; Gilbert, Dennis A.; Wright, Crystal; Lipzen, Anna; Pennacchio, Len A.; Carmichael, Suzan L.; Witte, John S.; Shaw, Gary M.; Rine, Jasper // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Despite compelling epidemiological evidence that folic acid supplements reduce the frequency of neural tube defects (NTDs) in newborns, common variant association studies with folate metabolism genes have failed to explain the majority of NTD risk. The contribution of rare alleles as well as...

  • Bringing clarity to the role of MTHFR variants in neural tube defect prevention. Stover, Patrick J; MacFarlane, Amanda J; Field, Martha S // American Journal of Clinical Nutrition;Jun2015, Vol. 101 Issue 6, p1111 

    The author discusses guidelines released by the World Health Organization (WHO ) regarding the implementation, monitoring, and impact evaluation of interventions for preventing neural tube defects (NTDs). Topics include the factors that interact to determine folate status in humans such as...

  • Dietary folate, but not choline, modifies neural tube defect risk in Shmt1 knockout mice. Beaudin, Anna E.; Abarinov, Elena V.; Malysheva, Olga; Perry, Cheryll A.; Caudill, Marie; Stover, Patrick J. // American Journal of Clinical Nutrition;Jan2012, Vol. 95 Issue 1, p109 

    Background: Low dietary choline intake has been proposed to increase the risk of neural tube defects (NTDs) in human populations. Mice with reduced Shmt1 expression exhibit a higher frequency of NTDs when placed on a folate- and choline-deficient diet and may represent a model of human NTDs. The...

  • Poster 295: Split Cord Malformation in a Child With Left Foot Pronation: A Case Report. Tsai, Tobias J.; Michaud, Linda J. // PM & R: Journal of Injury, Function & Rehabilitation;Sep2009 Supplement 9S, Vol. 1, pS232 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics